Bill Maughan
Stock Analyst at Canaccord Genuity
(0.01)
# 4,368
Out of 4,735 analysts
14
Total ratings
12.5%
Success rate
-37.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $26 | $6.19 | +320.03% | 2 | Aug 13, 2024 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.44 | +514.75% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.32 | +581.82% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $30.00 | +123.33% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $35.89 | +195.35% | 3 | May 3, 2024 | |
| IPSC Century Therapeutics | Maintains: Buy | $22 → $24 | $0.90 | +2,574.99% | 1 | Mar 15, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $60 | $13.56 | +342.48% | 1 | Feb 21, 2024 | |
| MRUS Merus | Initiates: Buy | $45 | $39.74 | +13.24% | 1 | Nov 2, 2023 |
Y-mAbs Therapeutics
Aug 13, 2024
Maintains: Buy
Price Target: $26
Current: $6.19
Upside: +320.03%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.44
Upside: +514.75%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.32
Upside: +581.82%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $30.00
Upside: +123.33%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $35.89
Upside: +195.35%
Century Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.90
Upside: +2,574.99%
Bicycle Therapeutics
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $13.56
Upside: +342.48%
Merus
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $39.74
Upside: +13.24%